With substantial investment and time, three-dimensional (3D) printing, which was once imaginable only in realms of science fiction, has well and truly become a reality. 3D printing, which refers to a number of manufacturing technologies generating a physical model from digital transformation, is essentially an additive technique. This technology holds huge potential for the pharmaceutical and medical companies, as it will allow these companies to create more specific drugs and enable rapid production of medical implants. Let’s take a look at how 3D printing is shaping the MedTech space, while making it a lucrative sector for investors looking for long-term gains. How is 3D Printing Changing the Game in MedTech? In recent times, 3D anatomical models – tailored to a patient’s specific needs – are gaining prominence as useful tools in the present day practice of precision medicine and personalized treatments. Although 3D printing is still under development, it has been implemented in countless innovative ways in the medical space that stands to gain significantly from this technology. In the near future, there is a probability of 3D-printed implantable organs becoming a reality, thereby lowering the waiting lists and increasing the number of lives saved. No doubt, 3D printing has garnered a positive response from the companies in the MedTech space within healthcare. Per a report by Market Data Forecast, the global 3D printing medical devices market (estimated at $1.48 billion in 2018) is projected to reach $5.59 billion by 2023 growing at a CAGR of 30.5%. MedTech’s 3D Printing Feats so Far Although most of the sectors within MedTech are making substantial efforts to create innovative products in the growing and lucrative 3D printing market, we will take a look at two sectors making most of the trend. 3D printing has had a huge impact on the dental space, in terms of increased efficiency, costs reduction and quality improvement. Orthodontic models, dentures and crown and bridge models are some of solid dental models revolutionizing the dental industry. Per a report by Markets and Markets, the dental 3D printing market (valued at $1.39 billion in 2017) is expected to see a CAGR of 23.2% and reach $5.06 billion by 2023. Another sector grabbing attention is the orthopedic space, where 3D printing is finding increasing application in the development of customized surgical implants. Through 3D printing, manufacturers are being able to develop implants of customized sizes and shapes in a short time, improving efficacy and lowering the overall cost of surgeries. Per a report by Research and Markets, orthopedic 3D printing devices market is expected to witness a CAGR of around 26% by 2023. 3 Stocks Gaining Prominence in 3D Printing Stryker Corporation SYK is one of the early adopters of the 3D printing technology and has become a leader in 3D printed titanium implants. The company has been making efforts in the expansion of its Tritanium cages, including FDA-approved Tritanium TL Curved Posterior Lumbar Cage. This is a 3D-printed interbody fusion cage intended for use as an aid in lumbar fixation. This Zacks Rank #3 (Hold) company has a long-term earnings growth rate of 9.8%. For 2019, the Zacks Consensus Estimate for revenues is pegged at $14.87 billion, indicating an improvement of 9.3% from the year-ago period. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Year to date, Stryker’s shares gained 40.4%, outperforming the industry’s rally of 16.9%.
Medtronic plc MDT has been making continued investments in 3D printing technology to stay ahead of the curve. Notably, in 2018, the company launched a titanium 3D printed platform – TiONIC technology – enabling more complex designs and integrated surface technologies for spine surgery implants. Further, Medtronic uses Stratasys’ SSYS 3D printing solutions for medical tools, functional prototypes. The company has a long-term earnings growth rate of 7.3%. For 2019, the Zacks Consensus Estimate for revenues is pegged at $31.50 billion, suggesting growth of 3.1% from the year-ago period. The company carries a Zacks Rank #2 (Buy). Shares of Medtronic gained 21.3% year to date, outperforming the industry’s growth of 16.8%.
Last year, Orthofix Medical Inc. OFIX announced the FDA approval and U.S. limited launch of the Forza XP Expandable Spacer System. This system consists of 3D printed porous titanium endplates, which enable the patient's bone to grow into the porous plate. Orthofix has a long-term earnings growth rate of 10%. For 2019, the Zacks Consensus Estimate for revenues is pegged at $473.7 million, indicating growth of 4.6% from the year-ago period. The company carries a Zacks Rank of 3. Over the last three months, shares of Orthofix gained 1.1%, outperforming the industry’s growth of 0.8%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Stratasys, Ltd. (SSYS) : Free Stock Analysis Report ORTHOFIX MEDICAL INC. (OFIX) : Free Stock Analysis Report Medtronic PLC (MDT) : Free Stock Analysis Report Stryker Corporation (SYK) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
The major stock market indexes relinquished morning gains in afternoon trading on Friday, dropping to lows for the day. Market players hit the exits on news that Russia will suspend natural gas pipeline shipments to Germany. The Nasdaq changed course, now down 0.5%. The S&P 500 has shed 0.2% while the Dow Jones Industrial Average has dropped 0.2%. The Russell...
‘Rich Dad Poor Dad’ sees a window to get rich. He might be right.
(Bloomberg) -- Amazon.com Inc., determined to reduce the size of its sprawling delivery operation amid slowing sales growth, has abandoned dozens of existing and planned facilities around the US, according to a closely watched consulting firm. Most Read from BloombergAmazon Closes, Abandons Plans for Dozens of US WarehousesGazprom Won’t Reopen Gas Pipeline in Energy Shock to EuropeUK Slips Behind India to Become World’s Sixth Biggest EconomyStocks Suffer Third Weekly Loss on Rate-Hike Woes: Mark
Follow Buffett’s lead. And collect big dividends too.
Cathie Wood's ARK Invest cut its stake in Nvidia ahead of the graphic chipmaker's results last month. Now it's snapped up the stock which has dropped to a 52-week low.
Chinese stocks have come under pressure for various reasons over the past year and a half or so; a slowing economy has been one cause while domestic tussles with the regulators haven’t helped either, particularly for those in the tech sector. Another element keeping sentiment low and impacting performance has been the fear of de-listing for U.S.-listed Chinese stocks. This is on account of Chinese companies not meeting U.S. auditing standards. But the prospects of de-listing might be less likely
Five years after Amazon announced that it would buy supermarket chain Whole Foods for $13.7 billion, a big new change has just taken place -- on September 1, incoming chief executive Jason Buechel is taking over for John Mackey. "As a co-founder of Whole Foods, I've often explained my relationship to the company with a parent-child metaphor," Buechel wrote in a letter announcing his retirement to Whole Foods Staff in September 2021. The transition took nearly a year and, now, former Chief Operating Officer Jason Buechel is stepping in to lead the high-end supermarket chain.
NIO Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $NIO performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter. Check out the ticker page here.
Orchid Island Capital Corp. (NYSE: ORC) is a finance company that acquires, invests in and offers financing from U.S. residential mortgage-backed securities (MBS). The Florida mortgage real estate investment trust (REIT) initiated an IPO in March 2013 at a price of $14.50. Its monthly dividend of $0.135 returned an approximate annual yield of 11%. However, in the last few years, the stock price has floundered, and ORC has reduced its dividend payment several times. Orchid’s price had recently be
In this article, we will take a look at the 10 tech stocks recently downgraded by analysts. If you want to see some other tech stocks receiving updated recommendations from analysts, go directly to Analysts are Downgrading These 5 Tech Stocks. Notable stocks from the tech sector, including HP Inc. (NYSE:HPQ), NVIDIA Corporation (NASDAQ:NVDA) and […]
Shat should investors do now if they are considering making a bet on the infamously volatile sector.
When a loved one passes away, it can be an emotional experience. Unfortunately, handling the deceased's finances can add to this stress. While most people know that you need to file a final tax return for the deceased, most people … Continue reading → The post Income in Respect of a Decedent (IRD) appeared first on SmartAsset Blog.
Yahoo Finance's Alexandra Semenova discusses the latest flows for Cathie Wood's ARKK Innovation Fund.
Investors initially cheered the payrolls report, but then the market sold off on fears of big rate hikes. Is it time to worry about quantitative tightening?
Finally, investors have a good reason for why the U.S. stock market will suffer above-average volatility and below-average performance this month: It’s the Fed. Relatively few advisers are focusing on this outcome — at least among the more than 100 I regularly monitor.
Nio's August deliveries soared year over year, but there are plenty of clouds on the horizon too.
The S&P 500 broke below 4,000 this week, for the first time since the end of July. It has investors wondering: Does this mark the low point of a roller coaster ride? Stocks rose all last year, fell from January to June, rallied from July to mid-August, and now are falling again. According to Wells Fargo strategist Paul Christopher, it’s evidence that the stock rally is sputtering to a halt. Christopher writes that “Cracks in financial market liquidity are appearing,” and says of the S&P 500, “3,
Yahoo Finance's Ines Ferré discusses how stocks are performing into the closing bell.
(Bloomberg) -- Investors bracing for a recession jolt accelerated their retreat from stocks after the Federal Reserve warned it won’t be easily deterred in its fight against inflation, Bank of America Corp. strategists say.Most Read from BloombergAmazon Closes, Abandons Plans for Dozens of US WarehousesGazprom Won’t Reopen Gas Pipeline in Energy Shock to EuropeStocks Suffer Third Weekly Loss on Rate-Hike Woes: Markets WrapLukoil Chairman Ravil Maganov Dies After Falling From Hospital WindowGloba
The major indexes broke more key support last week. Apple unveils the iPhone 14 Wednesday. AAPL stock is worth watching, but this tech leader looks better.